共查询到20条相似文献,搜索用时 0 毫秒
1.
Louise O’Donnell Bridgette Soileau Patricia Heard Erika Carter Courtney Sebold Jon Gelfond Daniel E. Hale Jannine D. Cody 《Human genetics》2010,128(2):155-164
Previous research has suggested that individuals with constitutional hemizygosity of 18q have a higher risk of autistic-like
behaviors. We sought to identify genomic factors located on chromosome 18 as well as other loci that correlate with autistic
behaviors. One hundred and five individuals with 18q- were assessed by high-resolution oligo aCGH and by parental ratings
of behavior on the Gilliam Autism Rating Scale. Forty-five individuals (43%) had scores within the “possibly” or “very likely”
categories of risk for an autism diagnosis. We searched for genetic determinants of autism by (1) identifying additional chromosome
copy number changes (2) Identifying common regions of hemizygosity on 18q, and (3) evaluating four regions containing candidate
genes located on 18q (MBD1, TCF4, NETO1, FBXO15). Three individuals with a “very likely” probability of autism had a captured 17p telomere in addition to the 18q deletion
suggesting a possible synergy between hemizygosity of 18q and trigosity of 17p. In addition, two of the individuals with an
18q deletion and a “very likely” probability of autism rating had a duplication of the entire short arm of chromosome 18.
Although no common region of hemizygosity on 18q was identified, analysis of four regions containing candidate genes suggested
that individuals were significantly more likely to exhibit autistic-like behaviors if their region of hemizygosity included
TCF4, NETO1, and FBXO15 than if they had any other combination of hemizygosity of the candidate genes. Taken together, these findings identify several
new potential candidate genes or regions for autistic behaviors. 相似文献
2.
MacKenzie RG 《Peptides》2006,27(2):395-403
Mutations in the human melanocortin-4 receptor (MC4R) gene have been associated with severe obesity. Many of the mutations result in partial or complete loss-of-function based on the nature of the mutation or the function of mutated receptors when tested in heterologous expression systems. This review discusses the role of MC4R in the central regulation of body weight, the pathogenic mechanisms of the mutations, and the validity of MC4R as an anti-obesity drug target. 相似文献
3.
The goal of this study is to define the effects of TCF4 hemizygosity in the context of a larger segmental deletion of chromosome 18q. Our cohort included 37 individuals with deletions
of 18q. Twenty-seven had deletions including TCF4 (TCF4
+/−); nine had deletions that did not include TCF4 (TCF4
+/+); and one individual had a microdeletion that included only the TCF4 gene. We compared phenotypic data from the participants’ medical records, survey responses, and in-person evaluations. Features
unique to the TCF4
+/− individuals included abnormal corpus callosum, short neck, small penis, accessory and wide-spaced nipples, broad or clubbed
fingers, and sacral dimple. The developmental data revealed that TCF4
+/+ individuals were only moderately developmentally delayed while TCF4
+/− individuals failed to reach developmental milestones beyond those typically acquired by 12 months of age. TCF4 hemizygosity also conferred an increased risk of early death principally due to aspiration-related complications. Hemizygosity
for TCF4 confers a significant impact primarily with regard to cognitive and motor development, resulting in a very different prognosis
for individuals hemizygous for TCF4 when compared to individuals hemizygous for other regions of distal 18q. 相似文献
4.
G Strathdee R Sutherland J J Jonsson R Sataloff M Kohonen-Corish D Grady J Overhauser 《American journal of human genetics》1997,60(4):860-868
The 18q- syndrome is a deletion syndrome that is characterized by mental retardation, hearing loss, midfacial hypoplasia, growth deficiency, and limb anomalies. Most patients with this syndrome have deletions from 18q21-qter. We report on three patients with deletions of 18q23. A mother and daughter with identical deletions of 18q23 have many of the typical features of the 18q- syndrome, including midfacial hypoplasia and hearing loss. In contrast, the third patient has few of the symptoms of the 18q- syndrome. A contig of the 18q23 region was generated to aid in the mapping of the breakpoints. FISH was used to map both breakpoints to the same YAC clone. Furthermore, somatic-cell hybrids from the daughter and the third patient were isolated. The mapping results of sequence-tagged sites relative to the two breakpoints were identical, suggesting that the two deletion breakpoints map very close to one another. The analyses of these patients demonstrate that the critical region for the 18q- syndrome maps to 18q23 but that a deletion of 18q23 does not always lead to the clinical features associated with the syndrome. These patients demonstrate the wide phenotypic variability associated with deletions of 18q. 相似文献
5.
The melanocortin-4 receptor (MC4R) plays an important role in weight and energy homeostasis and it is associated with lower
risk to develop obesity and lower body mass index. The contribution of MC4R mutation to obesity in Vojvodina (Northern Province
of Serbia), known as a region with the largest number of overweight people, has not been previously investigated. The objective
of this study was to examine the Val103Ile polymorphism of MC4R in a population of Vojvodina and its association with obesity.
The study was carried out in a group of 96 persons: 62 obese and 34 normal weight men and women. Anthropometric measurements
and cardiovascular risk factors assessment were done. The genotypes were determined by PCR-RFLP. In our on going study, three subjects were heterozygous for Val103Ile mutation (3.12%), and one was homozygous for 103Ile allele (1.04%).
Among obese patients no isoleucine allele homozygous was found. The frequencies of the 103Ile allele in a group of obese and
normal weight persons were found to be 1.61 and 4.41%, respectively. Val103Ile polymorphism of melanocortin-4 receptor is
unlikely to be a major cause of overweight and obesity in Vojvodina, but further studies on larger groups of patients are
needed. 相似文献
6.
G. Strathdee W. Harrison H. C. Riethman S. A. Goodart J. Overhauser 《American journal of human genetics》1994,54(6):1085-1091
Most patients who present with the 18q- syndrome have an apparent terminal deletion of the long arm of chromosome 18. For precise phenotypic mapping of this syndrome, it is important to determine whether the deletions are terminal deletions or interstitial deletions. A human telomeric YAC clone has been identified that hybridizes specifically to the telomeric end of 18q. This clone was characterized and used to analyze seven patients with 18q deletions. By FISH and Southern blotting analysis, all patients were found to lack this chromosomal region on their deleted chromosome, demonstrating that the patients do not have cryptic interstitial deletions. 相似文献
7.
Buchbinder S Bärtsch U Müller M Zorn M Nawroth PP Schilling T 《Genetics and molecular research : GMR》2011,10(2):1042-1049
Mutations in the melanocortin-4 receptor (MC4R) are associated with severe obesity, independent of their effect on cortisol or thyroid-stimulating hormone levels. We examined a morbidly obese male (BMI = 62 kg/m2) with a binge-eating disorder and eight family members for mutations in the MC4R gene and potential differences in leptin levels. Fifty healthy individuals served as controls. Sequence analysis revealed a novel heterozygous missense mutation (c.302 C>A, p.T101N) located in the second transmembrane domain of the receptor, which was not detected in controls. The Fisher exact test revealed an association between the T101N mutation and history of obesity (P < 0.05) in the family. The Kruskal-Wallis test showed an association between the mutation and the leptin/BMI ratio (P < 0.05), while there was no association between the T101N mutation and diabetes or arterial hypertension in the family. Although the available family was small, we could show a significant association between the heterozygous T101N mutation and obesity. 相似文献
8.
Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sina M Hinney A Ziegler A Neupert T Mayer H Siegfried W Blum WF Remschmidt H Hebebrand J 《American journal of human genetics》1999,65(6):1501-1507
Recently, haploinsufficiency mutations in the melanocortin-4 receptor gene (MC4-R) were detected which were assumed to lead to the phenotype of extreme obesity. Previously, we detected three obese carriers among 306 index patients. Here we describe the detection of one haploinsufficiency carrier in an additional study group of 186 obese individuals. We subsequently genotyped and phenotyped 43 family members of these four index patients, two of whom were second-degree cousins. A total of 19 carriers were identified. Extreme obesity was the predominating phenotype. However, moderate obesity occurred in three of the carriers. No other specific phenotypic abnormalities were detected. Female haploinsufficiency carriers were heavier than male carriers in the respective families, a finding similar to findings in MC4-R-knockout mice. In conclusion, our data fully support the etiologic role of MC4-R haploinsufficiency mutations in obesity. 相似文献
9.
Jiang W Tucci FC Chen CW Arellano M Tran JA White NS Marinkovic D Pontillo J Fleck BA Wen J Saunders J Madan A Foster AC Chen C 《Bioorganic & medicinal chemistry letters》2006,16(17):4674-4678
A series of 3-arylpropionylpiperazines were synthesized as antagonists of the melanocortin-4 receptor. Their potency was found to be increased by replacing the alpha-methyl substituent of the initial lead 11 with a larger s-Bu or i-Bu group. Further potency enhancement was observed when a glycine or beta-alanine was incorporated onto the benzylamine. Some compounds demonstrated good potency, moderate selectivity, and oral bioavailability. 相似文献
10.
Chen CW Tran JA Jiang W Tucci FC Arellano M Wen J Fleck BA Marinkovic D White NS Pontillo J Saunders J Madan A Foster AC Chen C 《Bioorganic & medicinal chemistry letters》2006,16(18):4800-4803
A series of alpha-benzylpropionylpiperazines were synthesized and tested as antagonists of the melanocortin-4 receptor. In addition to its high potency and selectivity, R-11a had desirable pharmacokinetic properties including high brain penetration in mice. 相似文献
11.
Fleck BA Chen C Yang W Huntley R Markison S Nickolls SA Foster AC Hoare SR 《Biochemistry》2005,44(44):14494-14508
The melanocortin-4 (MC4) receptor is a potential therapeutic target for obesity and cachexia, for which nonpeptide agonists and antagonists are being developed, respectively. The aim of this study was to identify molecular interactions between the MC4 receptor and nonpeptide ligands, and to compare the mechanism of binding between agonist and antagonist ligands. Nonpeptide ligand interaction was affected by mutations that reduce peptide ligand binding (D122A, D126A, S190A, M200A, F261A, and F284A), confirming overlapping binding determinants for peptide and nonpeptide ligands. The common halogenated phenyl group of nonpeptide ligands was a determinant of F261A and F284A mutations' affinity-reducing effect, implying this group interacts with the aromatic side chains of these residues. All affected compounds contain this group, the mutations reduced binding of 2,4-dichloro-substituted compounds more than 4-chloro-substituted-compounds, and F284A mutation eliminated the affinity-enhancing effect of 2-chloro-substitution. F261A and F284A mutations reduced the affinity of antagonists more than agonists, suggesting that the stronger ligand interaction with these residues, the lower the ligand efficacy. Supporting this hypothesis, F261A mutation increased the efficacy of nonpeptide antagonist and partial agonist ligands. D122A and D126A mutations reduced nonpeptide ligand interaction. Removing the ligands' derivatized amide group eliminated the effect of the mutations. Interaction of agonists, which bear a common amine within this group, was strongly reduced by D126A mutation (550-3300-fold), suggesting an electrostatic interaction between the amine and the acidic group of D126. These postulated interactions with aromatic and acidic regions of the MC4 receptor are consistent with a molecular model of the receptor. Furthermore, the strength of interaction with the aromatic pocket, and potentially the acidic pocket, controls the signaling efficacy of the ligand. 相似文献
12.
The melanocortins, which are derived from proopiomelanocortin, have a variety of physiological functions mediated membrane surface receptors. To date, five subtypes have been cloned. With the cloning of melanocortin receptors, studies with genetic models, and development of selective compounds, the physiological roles of the five melanocortin receptors have begun to be understood. The melanocortin-4 receptor (MC4R), which is predominantly expressed in the central nervous system, has in particular become the focus of much attention in recent years because of the critical roles it plays in a wide range of functions, including feeding, sexual behavior, and stress. Recent development of selective antagonists for the MC4R has provided pharmacological evidence that blockade of MC4R could be a useful way of alleviating numerous conditions such as anxiety/depression, pain, and addiction to drugs of abuse. 相似文献
13.
Functional characterization of mutations in melanocortin-4 receptor associated with human obesity 总被引:11,自引:0,他引:11
Melanocortin-4 receptor (MC4R) is a G protein-coupled receptor implicated in the regulation of body weight. Genetic studies in humans have identified two frameshift mutations of MC4R associated with a dominantly inherited form of obesity. We have generated and expressed the corresponding MC4R mutants in 293T cells and found that cells transfected with the truncation mutants failed to exhibit agonist binding or responsiveness despite retention of structural motifs potentially sufficient for binding and signaling. Immunofluorescence studies showed that the mutant proteins were expressed and localized in the intracellular compartment but absent from the plasma membrane, suggesting that these mutations disrupted the proper cellular transport of MC4R. Further studies identified a sequence in the cytoplasmic tail of MC4R necessary for the cell surface targeting. We further investigated a possible dominant-negative activity of the mutants on wild-type receptor function. Co-transfection studies showed that the mutants affected neither signaling nor cell surface expression of wild-type MC4R. We also characterized three human sequence variants of MC4R, but these exhibited identical affinities for peptide ligands and identical agonist responsiveness. Thus, unlike the obesity-associated MC4R truncation mutants, the polymorphisms of MC4R are unlikely to be contributors to human obesity. 相似文献
14.
Nozawa D Okubo T Ishii T Takamori K Chaki S Okuyama S Nakazato A 《Bioorganic & medicinal chemistry》2007,15(6):2375-2385
In the present study, we found that a novel piperazine compound, 11a, showed a moderate affinity (IC(50)=333nM) for the MC4 receptor. We developed the new type of piperazine compounds and found that mono-piperazine 11b exhibited a high-affinity (IC(50)=40.3nM) for the MC4 receptor. We also found that a series of biphenyl analogues exhibited a high-affinity for the receptor, and in particular, compound 11j exhibited the highest affinity for the MC4 receptor with an IC(50) value of 14.5nM. Furthermore, some of these compounds, when administered orally, significantly reversed the stress-induced anxiety-like behavior in rats. In this paper, we report the synthesis, structure-activity relationships, and oral activity of the novel mono-piperazines as MC4 receptor antagonists. 相似文献
15.
Polymorphism and chromosomal location of the MC4R (melanocortin-4 receptor) gene in the dog and red fox 总被引:3,自引:0,他引:3
Skorczyk A Stachowiak M Szczerbal I Klukowska-Roetzler J Schelling C Dolf G Switonski M 《Gene》2007,392(1-2):247-252
The melanocortin-4 receptor (MC4R) is expressed in the hypothalamus and regulates energy intake and body weight. In silico screening of the canine chromosome 1 sequence and a comparison with the porcine MC4R sequence by BLAST were performed. The nucleotide sequence of the whole coding region and 3'- and 5'-flanking regions of the dog (1214 bp) and red fox (1177 bp) MC4R gene was established and high conservation of the nucleotide sequences was revealed (99%). Five sets of PCR primers were designed and a search for polymorphism was performed by the SSCP technique in a group of 31 dogs representing nineteen breeds and 35 farm red foxes. Sequencing of DNA fragments, representing the identified SSCP patterns, revealed three single nucleotide polymorphisms (including a missense one) in dogs and four silent SNPs in red foxes. An average SNP frequency was approx. 1/400 bp in the dog and 1/300 bp in the red fox. We mapped the MC4R gene by FISH to the canine chromosome 1 (CFA1q1.1) and to the red fox chromosome 5 (VVU5p1.2). 相似文献
16.
Yang YK Fong TM Dickinson CJ Mao C Li JY Tota MR Mosley R Van Der Ploeg LH Gantz I 《Biochemistry》2000,39(48):14900-14911
To elucidate the molecular basis for the interaction of ligands with the human melanocortin-4 receptor (hMC4R), agonist structure-activity studies and receptor point mutagenesis were performed. Structure-activity studies of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) identified D-Phe7-Arg8-Trp9 as the minimal NDP-MSH fragment that possesses full agonist efficacy at the hMC4R. In an effort to identify receptor residues that might interact with amino acids in this tripeptide sequence 24 hMC4R transmembrane (TM) residues were mutated (the rationale for choosing specific receptor residues for mutation is outlined in the Results section). Mutation of TM3 residues D122 and D126 and TM6 residues F261 and H264 decreased the binding affinity of NDP-MSH 5-fold or greater, thereby identifying these receptor residues as sites potentially involved in the sought after ligand-receptor interactions. By examination of the binding affinities and potencies of substituted NDP-MSH peptides at receptor mutants, evidence was found that core melanocortin peptide residue Arg8 interacts at a molecular level with hMC4R TM3 residue D122. TM3 mutations were also observed to decrease the binding of hMC4R antagonists. Notably, mutation of TM3 residue D126 to alanine decreased the binding affinity of AGRP (87-132), a C-terminal derivative of the endogenous melanocortin antagonist, 8-fold, and simultaneous mutations D122A/D126A completely abolished AGRP (87-132) binding. In addition, mutation of TM3 residue D122 or D126 decreased the binding affinity of hMC4R antagonist SHU 9119. These results provide further insight into the molecular determinants of hMC4R ligand binding. 相似文献
17.
Thomas P. Meehan Koichi Tabeta Xin Du Lanette S. Woodward Karen Firozi Bruce Beutler Monica J. Justice 《Mammalian genome》2006,17(12):1162-1171
Mutations in the melanocortin-4 receptor (MC4R) are associated with early-onset obesity in humans. Furthermore, a null Mc4r allele in mice leads to severe obesity due to hyperphagia and decreased energy expenditure. As part of independent N-ethyl- N-nitrosourea (ENU) mutagenesis screens, two obesity mutants, Fatboy and Southbeach, were isolated. Mapping revealed linkage to the melanocortin-4 receptor (Mc4r) and sequencing found single amino acid changes
in Mc4r for each line. Expression of the mutant receptors in HEK 293 cells revealed defects in receptor signaling. The mutated
Fatboy receptor (I194T) shows an increase in the effective concentration necessary for 50% of maximal signaling (EC50) when stimulated with α-MSH. Based on competitive binding, I194T is expressed on the cell surface at lower levels than the
nonmutated receptor. In contrast, Southbeach (L300P) displays minimal receptor signaling when stimulated with the natural ligand α-MSH or the synthetic agonist NDP-α-MSH.
Cell surface binding is absent, which usually indicates a lack of cell surface expression. However, antibody binding to Flag-tagged
receptors by flow cytometry analysis and immunofluorescence demonstrates that L300P is translocated to the plasma membrane
at a level comparable to the wild-type receptor. These results indicate a correlation with remaining receptor activity and
the severity of the obesity in the mice homozygous for the mutations. Southbeach has less receptor activity and becomes more obese. These mutants will serve as good models for the variability in phenotype
in humans carrying mutations in the MC4R gene. 相似文献
18.
Jiang W Tucci FC Tran JA Fleck BA Wen J Markison S Marinkovic D Chen CW Arellano M Hoare SR Johns M Foster AC Saunders J Chen C 《Bioorganic & medicinal chemistry letters》2007,17(20):5610-5613
A series of pyrrolidinones derived from phenylalaninepiperazines were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor. In addition to their high binding affinities, these compounds displayed high functional potencies. 12a had a K(i) of 0.94 nM in binding and IC(50) of 21 nM in functional activity. 12a also demonstrated efficacy in a mouse cachexia model. 相似文献
19.
Tran JA Tucci FC Jiang W Marinkovic D Chen CW Arellano M Markison S Fleck BA Wen J White NS Pontillo J Saunders J Marks D Hoare SR Madan A Foster AC Chen C 《Bioorganic & medicinal chemistry》2007,15(15):5166-5176
A series of pyrrolidinones derived from phenylalanines were synthesized as potent antagonists of the human melanocortin-4 receptor. These compounds showed high potencies and selectivities, and several of them had good oral bioavailabilities. In addition, 12e demonstrated in vivo efficacy in a murine cachexia model. 相似文献
20.
Tran JA Chen CW Jiang W Tucci FC Fleck BA Marinkovic D Arellano M Chen C 《Bioorganic & medicinal chemistry letters》2007,17(18):5165-5170
A series of pyrrolidine derivatives were synthesized and characterized as potent agonists of the human melanocortin-4 receptor. For example, 28c had a K(i) of 13 nM in binding affinity and EC(50) of 6.9 nM in agonist potency with an intrinsic activity of 100% of the endogenous ligand alpha-MSH. 相似文献